{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T07:10:07Z","timestamp":1758957007116,"version":"3.44.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009694","name":"Bu-Ali Sina University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010016","name":"Nottingham Trent University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comparative Immunology, Microbiology and Infectious Diseases"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.cimid.2023.102011","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T20:45:26Z","timestamp":1687812326000},"page":"102011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluation of murine OX40L-murine IgG1(MM1) fusion protein on immunogenicity against L. mexicana infection in BALB\/c mice"],"prefix":"10.1016","volume":"99","author":[{"given":"Hossein","family":"Rezvan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selman A.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar","family":"Hamoon Navard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Rees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cimid.2023.102011_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0065-2776(10)05003-0","article-title":"OX40\u2013OX40 ligand interaction in T-cell-mediated immunity and immunopathology","volume":"105","author":"Ishii","year":"2010","journal-title":"Adv. Immunol."},{"issue":"2","key":"10.1016\/j.cimid.2023.102011_bib2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1084\/jem.191.2.365","article-title":"Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand","volume":"191","author":"Murata","year":"2000","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.cimid.2023.102011_bib3","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1681\/ASN.V1181426","article-title":"Strong and selective glomerular localization of CD134 ligand and TNF receptor-1 in proliferative lupus nephritis","volume":"11","author":"Aten","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"issue":"13","key":"10.1016\/j.cimid.2023.102011_bib4","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1016\/j.celrep.2018.12.006","article-title":"OX40 regulates both innate and adaptive immunity and promotes nonalcoholic steatohepatitis","volume":"25","author":"Sun","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.cimid.2023.102011_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/6804806","article-title":"Increased expressions of OX40 and OX40 ligand in patients with primary immune thrombocytopenia","volume":"2019","author":"Cui","year":"2019","journal-title":"J. Immunol. Res."},{"issue":"3","key":"10.1016\/j.cimid.2023.102011_bib6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1074-7613(01)00191-1","article-title":"OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells","volume":"15","author":"Rogers","year":"2001","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.cimid.2023.102011_bib7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1084\/jem.191.2.375","article-title":"Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis","volume":"191","author":"Akiba","year":"2000","journal-title":"J. Exp. Med"},{"issue":"5","key":"10.1016\/j.cimid.2023.102011_bib8","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/eji.200324021","article-title":"Immunotherapy with OX40L-Fc or anti-CTLA-4 enhances local tissue responses and killing of Leishmania donovani","volume":"34","author":"Zubairi","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cimid.2023.102011_bib9","unstructured":"Rezvan H. Studies on immunology of leishmania mexicana: Nottingham Trent University (United Kingdom); 2007."},{"issue":"3","key":"10.1016\/j.cimid.2023.102011_bib10","first-page":"423","article-title":"Leishmaniasis vaccine candidates for development: a global overview","volume":"123","author":"Khamesipour","year":"2006","journal-title":"Indian J. Med. Res."},{"issue":"6","key":"10.1016\/j.cimid.2023.102011_bib11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3347\/kjp.2022.60.6.379","article-title":"Leishmania vaccines: the current situation with its promising aspect for the future","volume":"60","author":"Dinc","year":"2022","journal-title":"Korean J. Parasitol."},{"issue":"5","key":"10.1016\/j.cimid.2023.102011_bib12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4103\/1995-7645.345944","article-title":"New developments in the treatment of cutaneous leishmaniasis","volume":"15","author":"Dinc","year":"2022","journal-title":"Asian Pacific J. Trop. Med."},{"issue":"27\u201328","key":"10.1016\/j.cimid.2023.102011_bib13","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1016\/j.vaccine.2004.03.041","article-title":"Anti-tumour therapeutic efficacy of OX40L in murine tumour model","volume":"22","author":"Ali","year":"2004","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.cimid.2023.102011_bib14","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.apsb.2019.08.010","article-title":"Therapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity","volume":"10","author":"Fu","year":"2020","journal-title":"Acta Pharm. Sin. B."},{"issue":"5","key":"10.1016\/j.cimid.2023.102011_bib15","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.chom.2015.03.007","article-title":"PD-1 co-inhibitory and OX40 co-stimulatory crosstalk regulates helper T cell differentiation and anti-Plasmodium humoral immunity","volume":"17","author":"Zander","year":"2015","journal-title":"Cell Host Microbe"},{"issue":"7","key":"10.1016\/j.cimid.2023.102011_bib16","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.celrep.2017.10.077","article-title":"Th1-like plasmodium-specific memory CD4+ T cells support humoral immunity","volume":"21","author":"Zander","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.cimid.2023.102011_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.620144","article-title":"Unraveling the role of immune checkpoints in leishmaniasis","volume":"12","author":"de Freitas e Silva","year":"2021","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.cimid.2023.102011_bib18","doi-asserted-by":"crossref","first-page":"6520","DOI":"10.4049\/jimmunol.163.12.6520","article-title":"Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40)","volume":"163","author":"Pippig","year":"1999","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.cimid.2023.102011_bib19","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1002\/eji.200324031","article-title":"OX40 (CD134) and OX40 ligand interaction plays an adjuvant role during in vivo Th2 responses","volume":"33","author":"Ishii","year":"2003","journal-title":"Eur. J. Immunol."},{"issue":"9","key":"10.1016\/j.cimid.2023.102011_bib20","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1182\/blood.V92.9.3338","article-title":"OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4(+) T cells into high IL-4-producing effectors","volume":"92","author":"Ohshima","year":"1998","journal-title":"Blood"},{"issue":"2\u20134","key":"10.1016\/j.cimid.2023.102011_bib21","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1159\/000024143","article-title":"OX40-Mediated cosignal enhances the maturation of naive human CD4+ T cells into high IL-4-producing effectors","volume":"118","author":"Delespesse","year":"1999","journal-title":"Int Arch. Allergy Immunol."},{"issue":"3","key":"10.1016\/j.cimid.2023.102011_bib22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1084\/jem.192.3.405","article-title":"Human monocyte-derived dendritic cells induce naive T cell differentiation into T helper cell type 2 (Th2) or Th1\/Th2 effectors. Role of stimulator\/responder ratio","volume":"192","author":"Tanaka","year":"2000","journal-title":"J. Exp. Med"},{"issue":"2","key":"10.1016\/j.cimid.2023.102011_bib23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1084\/jem.188.2.297","article-title":"CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1","volume":"188","author":"Flynn","year":"1998","journal-title":"J. Exp. Med"},{"issue":"35","key":"10.1016\/j.cimid.2023.102011_bib24","doi-asserted-by":"crossref","first-page":"13138","DOI":"10.1073\/pnas.0603107103","article-title":"OX40 ligand shuts down IL-10-producing regulatory T cells","volume":"103","author":"Ito","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.cimid.2023.102011_bib25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1084\/jem.191.2.365","article-title":"Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand","volume":"191","author":"Murata","year":"2000","journal-title":"J. Exp. Med"},{"issue":"3","key":"10.1016\/j.cimid.2023.102011_bib26","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1006\/bbrc.2000.2560","article-title":"Characterization of rat OX40 ligand by monoclonal antibody","volume":"270","author":"Satake","year":"2000","journal-title":"Biochem Biophys. Res Commun."},{"issue":"8","key":"10.1016\/j.cimid.2023.102011_bib27","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.4049\/jimmunol.159.8.3838","article-title":"Expression and function of OX40 ligand on human dendritic cells","volume":"159","author":"Ohshima","year":"1997","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cimid.2023.102011_bib28","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1399-0039.2004.00300.x","article-title":"Characterization and functional study of five novel monoclonal antibodies against human OX40L highlight reverse signalling: enhancement of IgG production of B cells and promotion of maturation of DCs","volume":"64","author":"Wang","year":"2004","journal-title":"Tissue Antigens"},{"issue":"8","key":"10.1016\/j.cimid.2023.102011_bib29","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1182\/blood-2004-10-3944","article-title":"Enhancing the immunostimulatory function of dendritic cells by transfection with mRNA encoding OX40 ligand","volume":"105","author":"Dannull","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cimid.2023.102011_bib30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00262-005-0004-y","article-title":"Immunotherapeutic potential of DISC-HSV and OX40L in cancer","volume":"55","author":"Assudani","year":"2006","journal-title":"Cancer Immunol. Immunother."},{"issue":"27\u201328","key":"10.1016\/j.cimid.2023.102011_bib31","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1016\/j.vaccine.2004.03.041","article-title":"Anti-tumour therapeutic efficacy of OX40L in murine tumour model","volume":"22","author":"Ali","year":"2004","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.cimid.2023.102011_bib32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2217\/imt-2017-0082","article-title":"Radiation therapy and immunotherapy: what is the optimal timing or sequencing?","volume":"10","author":"Aliru","year":"2018","journal-title":"Immunotherapy"},{"issue":"2","key":"10.1016\/j.cimid.2023.102011_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1349-7006.2007.00664.x","article-title":"Anti\u2010OX40 monoclonal antibody therapy in combination with radiotherapy results in therapeutic antitumor immunity to murine lung cancer","volume":"99","author":"Yokouchi","year":"2008","journal-title":"Cancer Sci."},{"issue":"6","key":"10.1016\/j.cimid.2023.102011_bib34","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/infdis\/jir868","article-title":"OX40 ligand fusion protein delivered simultaneously with the BCG vaccine provides superior protection against murine Mycobacterium tuberculosis infection","volume":"205","author":"Snelgrove","year":"2012","journal-title":"J. Infect. Dis."}],"container-title":["Comparative Immunology, Microbiology and Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147957123000693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147957123000693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T06:48:17Z","timestamp":1758955697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147957123000693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":34,"alternative-id":["S0147957123000693"],"URL":"https:\/\/doi.org\/10.1016\/j.cimid.2023.102011","relation":{},"ISSN":["0147-9571"],"issn-type":[{"type":"print","value":"0147-9571"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of murine OX40L-murine IgG1(MM1) fusion protein on immunogenicity against L. mexicana infection in BALB\/c mice","name":"articletitle","label":"Article Title"},{"value":"Comparative Immunology, Microbiology and Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cimid.2023.102011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102011"}}